Clinical Trials Logo

Activation of Latent Virus clinical trials

View clinical trials related to Activation of Latent Virus.

Filter by:
  • None
  • Page 1

NCT ID: NCT02334943 Completed - Immune Deficiency Clinical Trials

Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment

Start date: March 2015
Phase: N/A
Study type: Interventional

Immune Activation persists in HIV-1 infected patients despite efficient antiretroviral treatment. This immune activation is responsible for immune deficiency as well as for non-AIDS related comorbidities, such as non-alcoholic Fatty liver disease, metabolic syndrome or osteoporosis. The goal of this observational transversal multicentric study is to establish the etiologic factors of persistent immune activation in treated HIV-1 infected patients (persistent de novo infection of T CD4+ cells, microbial translocation, active coinfections, immunosenescence, T CD4+ cells lymphopenia, Treg deficiency), its different forms ( activation of T CD4+ cells, T CD8+ cells, B cells, NK cells, monocytes, granulocytes, platelets, endothelial cells or general inflammation) and the potential correlation between causes, forms of immune activation and emergent comorbidities (kidney, bone or liver dysfunction, metabolic syndrome).